Tolerogenics Receives $50,000 New Funding

  • Feed Type
  • Date
    12/31/2009
  • Company Name
    Tolerogenics
  • Mailing Address
    20 N Wacker Dr Chicago, IL 60606-2901
  • Company Description
    The company is developing targeted approaches to the treatment of autoimmune diseases.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $50,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    IllinoisVentures

By posting a comment, you agree to our terms and conditions.